Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |